Ubiquitin-specific peptidase 22 functions and its involvement in disease
Oncotarget2016Vol. 7(28), pp. 44848–44856
Citations Over TimeTop 10% of 2016 papers
Abstract
Deubiquitylases remove ubiquitin moieties from different substrates to regulate protein activity and cell homeostasis. Since this posttranslational modification plays a role in several different cellular functions, its deregulation has been associated with different pathologies. Aberrant expression of the Ubiquitin-Specific Peptidase 22 (USP22) has been associated with poor cancer prognosis and neurological disorders. However, little is known about USP22 role in these pathologies or in normal physiology. This review summarizes the current knowledge about USP22 function from yeast to human and provides an overview of the possible mechanisms by which USP22 is emerging as a potential oncogene.
Related Papers
- → Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP(2013)76 cited
- → miR-135b-5p promotes gastric cancer progression by targeting CMTM3(2017)56 cited
- → MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer(2015)37 cited
- → Downregulation of microRNA‑142‑3p and its tumor suppressor role in gastric cancer(2018)30 cited
- → Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway(2018)21 cited